Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice

Santiago Vernia, Miguel Heredia, Olga Criado, Santiago Rodriguez de Cordoba, Pablo M Garcia-Roves, Céline Cansell, Raphael Denis, Serge Luquet, Fabienne Foufelle, Pascal Ferre, Pascual Sanz

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Laforin is a dual specificity protein phosphatase involved in Lafora disease (LD), a fatal form of progressive myoclonus epilepsy characterized by neurodegeneration and the presence of intracellular polyglucosan inclusions (Lafora bodies) in different tissues. In this work, we describe that mice lacking laforin (epm2a-/-) have enhanced insulin response leading to altered whole-body energy balance. This enhanced insulin response overactivates the Akt pathway which increases glucose uptake in the heart, resulting in increased glycogen levels and the formation of polyglucosan inclusions. In addition, enhanced insulin response resulted in increased liver lipid biosynthesis, resulting in hepatic steatosis. On the contrary, overexpression in rat hepatoma FTO2B cells of native laforin but not of a form lacking phosphatase activity (C266S) resulted in attenuation of insulin signaling. These results define laforin as a new regulator of insulin sensitivity, which provides novel insights into LD pathogenesis and identifies this phosphatase as a potential novel component of the insulin signaling cascade.

Original languageEnglish
Pages (from-to)2571-2584
Number of pages14
JournalHuman Molecular Genetics
Volume20
Issue number13
Early online date14 Apr 2011
DOIs
Publication statusPublished - 1 Jul 2011

Fingerprint

Lafora Disease
Dual-Specificity Phosphatases
Insulin
Phosphoric Monoester Hydrolases
Progressive Myoclonic Epilepsy
Phosphoprotein Phosphatases
Liver
Inclusion Bodies
Glycogen
Insulin Resistance
Hepatocellular Carcinoma
Lipids
Glucose

Keywords

  • Animals
  • Cell Line, Tumor
  • Disease Models, Animal
  • Dual-Specificity Phosphatases
  • Energy Metabolism
  • Female
  • Glucose
  • Insulin
  • Lafora Disease
  • Lipid Metabolism
  • Liver
  • Male
  • Mice
  • Mice, Knockout
  • Motor Activity
  • Myocardium
  • Rats
  • Signal Transduction

Cite this

Vernia, S., Heredia, M., Criado, O., Rodriguez de Cordoba, S., Garcia-Roves, P. M., Cansell, C., ... Sanz, P. (2011). Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice. Human Molecular Genetics, 20(13), 2571-2584. https://doi.org/10.1093/hmg/ddr157

Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice. / Vernia, Santiago; Heredia, Miguel; Criado, Olga; Rodriguez de Cordoba, Santiago; Garcia-Roves, Pablo M; Cansell, Céline; Denis, Raphael; Luquet, Serge; Foufelle, Fabienne; Ferre, Pascal; Sanz, Pascual.

In: Human Molecular Genetics, Vol. 20, No. 13, 01.07.2011, p. 2571-2584.

Research output: Contribution to journalArticle

Vernia, S, Heredia, M, Criado, O, Rodriguez de Cordoba, S, Garcia-Roves, PM, Cansell, C, Denis, R, Luquet, S, Foufelle, F, Ferre, P & Sanz, P 2011, 'Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice', Human Molecular Genetics, vol. 20, no. 13, pp. 2571-2584. https://doi.org/10.1093/hmg/ddr157
Vernia, Santiago ; Heredia, Miguel ; Criado, Olga ; Rodriguez de Cordoba, Santiago ; Garcia-Roves, Pablo M ; Cansell, Céline ; Denis, Raphael ; Luquet, Serge ; Foufelle, Fabienne ; Ferre, Pascal ; Sanz, Pascual. / Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice. In: Human Molecular Genetics. 2011 ; Vol. 20, No. 13. pp. 2571-2584.
@article{c625a629e9b749df8ea2ec849b8ab761,
title = "Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice",
abstract = "Laforin is a dual specificity protein phosphatase involved in Lafora disease (LD), a fatal form of progressive myoclonus epilepsy characterized by neurodegeneration and the presence of intracellular polyglucosan inclusions (Lafora bodies) in different tissues. In this work, we describe that mice lacking laforin (epm2a-/-) have enhanced insulin response leading to altered whole-body energy balance. This enhanced insulin response overactivates the Akt pathway which increases glucose uptake in the heart, resulting in increased glycogen levels and the formation of polyglucosan inclusions. In addition, enhanced insulin response resulted in increased liver lipid biosynthesis, resulting in hepatic steatosis. On the contrary, overexpression in rat hepatoma FTO2B cells of native laforin but not of a form lacking phosphatase activity (C266S) resulted in attenuation of insulin signaling. These results define laforin as a new regulator of insulin sensitivity, which provides novel insights into LD pathogenesis and identifies this phosphatase as a potential novel component of the insulin signaling cascade.",
keywords = "Animals, Cell Line, Tumor, Disease Models, Animal, Dual-Specificity Phosphatases, Energy Metabolism, Female, Glucose, Insulin, Lafora Disease, Lipid Metabolism, Liver, Male, Mice, Mice, Knockout, Motor Activity, Myocardium, Rats, Signal Transduction",
author = "Santiago Vernia and Miguel Heredia and Olga Criado and {Rodriguez de Cordoba}, Santiago and Garcia-Roves, {Pablo M} and C{\'e}line Cansell and Raphael Denis and Serge Luquet and Fabienne Foufelle and Pascal Ferre and Pascual Sanz",
year = "2011",
month = "7",
day = "1",
doi = "10.1093/hmg/ddr157",
language = "English",
volume = "20",
pages = "2571--2584",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "13",

}

TY - JOUR

T1 - Laforin, a dual specificity phosphatase involved in Lafora disease, regulates insulin response and whole-body energy balance in mice

AU - Vernia, Santiago

AU - Heredia, Miguel

AU - Criado, Olga

AU - Rodriguez de Cordoba, Santiago

AU - Garcia-Roves, Pablo M

AU - Cansell, Céline

AU - Denis, Raphael

AU - Luquet, Serge

AU - Foufelle, Fabienne

AU - Ferre, Pascal

AU - Sanz, Pascual

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Laforin is a dual specificity protein phosphatase involved in Lafora disease (LD), a fatal form of progressive myoclonus epilepsy characterized by neurodegeneration and the presence of intracellular polyglucosan inclusions (Lafora bodies) in different tissues. In this work, we describe that mice lacking laforin (epm2a-/-) have enhanced insulin response leading to altered whole-body energy balance. This enhanced insulin response overactivates the Akt pathway which increases glucose uptake in the heart, resulting in increased glycogen levels and the formation of polyglucosan inclusions. In addition, enhanced insulin response resulted in increased liver lipid biosynthesis, resulting in hepatic steatosis. On the contrary, overexpression in rat hepatoma FTO2B cells of native laforin but not of a form lacking phosphatase activity (C266S) resulted in attenuation of insulin signaling. These results define laforin as a new regulator of insulin sensitivity, which provides novel insights into LD pathogenesis and identifies this phosphatase as a potential novel component of the insulin signaling cascade.

AB - Laforin is a dual specificity protein phosphatase involved in Lafora disease (LD), a fatal form of progressive myoclonus epilepsy characterized by neurodegeneration and the presence of intracellular polyglucosan inclusions (Lafora bodies) in different tissues. In this work, we describe that mice lacking laforin (epm2a-/-) have enhanced insulin response leading to altered whole-body energy balance. This enhanced insulin response overactivates the Akt pathway which increases glucose uptake in the heart, resulting in increased glycogen levels and the formation of polyglucosan inclusions. In addition, enhanced insulin response resulted in increased liver lipid biosynthesis, resulting in hepatic steatosis. On the contrary, overexpression in rat hepatoma FTO2B cells of native laforin but not of a form lacking phosphatase activity (C266S) resulted in attenuation of insulin signaling. These results define laforin as a new regulator of insulin sensitivity, which provides novel insights into LD pathogenesis and identifies this phosphatase as a potential novel component of the insulin signaling cascade.

KW - Animals

KW - Cell Line, Tumor

KW - Disease Models, Animal

KW - Dual-Specificity Phosphatases

KW - Energy Metabolism

KW - Female

KW - Glucose

KW - Insulin

KW - Lafora Disease

KW - Lipid Metabolism

KW - Liver

KW - Male

KW - Mice

KW - Mice, Knockout

KW - Motor Activity

KW - Myocardium

KW - Rats

KW - Signal Transduction

U2 - 10.1093/hmg/ddr157

DO - 10.1093/hmg/ddr157

M3 - Article

C2 - 21493628

VL - 20

SP - 2571

EP - 2584

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 13

ER -